Three-dimensional trabecular bone architecture of the lumbar spine in bone metastasis from prostate cancer: Comparison with degenerative sclerosis

Skeletal Radiology

Volumn 34, Issue 3, 2005, Pages 149-155

  Tamada, Tsutomu ^a   Sone, Teruki ^a   Jo, Yoshimasa ^a   Imai, Shigeki ^a   Kajihara, Yasumasa ^a   Fukunaga, Masao ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Bone metastases; Microcomputed tomography (micro CT); Osteosclerosis; Prostate cancer; Three dimensional (3D) structure; Trabecular bone

Indexed keywords

ADULT; AGED; ARTICLE; AUTOPSY; BONE ATROPHY; BONE METASTASIS; BONE STRUCTURE; CANCELLOUS BONE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EXCISION; HUMAN; HUMAN TISSUE; IMAGE DISPLAY; IMAGE RECONSTRUCTION; INTERMETHOD COMPARISON; LUMBAR SPINE; MALE; MORPHOLOGY; OSTEOLYSIS; OSTEOSCLEROSIS; PRIORITY JOURNAL; PROSTATE CANCER; STATISTICAL SIGNIFICANCE; SURFACE PROPERTY; THICKNESS; THREE DIMENSIONAL IMAGING; TRABECULAR BONE; X RAY;

ADULT; AGED; ANALYSIS OF VARIANCE; CADAVER; HUMANS; IMAGING, THREE-DIMENSIONAL; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOSCLEROSIS; PROSTATIC NEOPLASMS; SPINAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 14544286987     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00256-004-0855-x     Document Type: Article

References (31)

1. Koutsilieris M. Osteoblastic metastasis in advanced prostate cancer. Anticancer Res 1993 13 443-450. 1:STN:280:ByyB1MjoslI%3D
2. Jacobs SC. Spread of prostatic cancer to bone. Urology 1983 21 337-344. 10.1016/0090-4295(83)90147-4
3. Charhon SA, Chapuy MC, Delvin EE, Valentin-Opran A, Edouard CM, Meunier PJ. Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma with special reference to osteomalacia. Cancer 1983 51 918-924. 1:STN:280:BiyC3c3otVI%3D
4. Aoki J, Yamamoto I, Hino M, et al. Sclerotic bone metastasis: radiologic-pathologic correlation. Radiology 1986 159 127-132. 1:STN:280:BimC2M%2FjtFU%3D
5. Clarke NW, McClure J, George NJR. Morphometric evidence for bone resorption and replacement in prostate cancer. Br J Urol 1991 68 74-80. 1:STN:280:By6A3sfpslE%3D
6. Odgaard A, Gundersen HJG. Quantification of connectivity in cancellous bone, with special emphasis on 3-D reconstructions. Bone 1993 14 173-182. 1:STN:280:ByyA38nks1E%3D
7. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Miner Res 1987 2 595-610. 1:STN:280:BieA3sfjsFc%3D
8. Hildebrand T, Rüegsegger P. A new method for the model-independent assessment of thickness in three-dimensional images. J Microsc 1997 185 67-75. 10.1046/j.1365-2818.1997.1340694.x
9. Hahn M, Vogel M, Pompesius-Kempa M, Delling G. Trabecular bone pattern factor: A new parameter for simple quantification of bone microarchitecture. Bone 1992 13 327-330 10.1016/8756-3282(92)90078-B
10. Whitehouse WJ. The quantitative morphology of anisotropic trabecular bone. J Microsc 1974 101 153-168. 4610138
11. Müller R, Hahn M, Vogel M, Delling G, Rüegsegger P. Morphometric analysis of noninvasively assessed bone biopsies: comparison of high-resolution computed tomography and histologic sections. Bone 1996 18 215-220. 10.1016/8756-3282(95)00489-0
12. Jorgensen SM, Demirkaya O, Ritman EL. Three-dimensional imaging of vasculature and parenchyma in intact rodent organs with X-ray micro-CT. Am J Physiol 1998 275 H1103-H1114.
13. Hildebrand T, Laib A, Müller R, Dequeker J, Rüegsegger P. Direct Three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 1999 14 1167-1174.
14. Müller R, Campenhout HV, Damme BV, et al. Morphometric analysis of human bone biopsies: A quantitative structural comparison of histological sections and micro-computed tomography. Bone 1998 23 59-66. 10.1016/S8756-3282(98)00068-4
15. Adami S. Bisphosphonates in prostate carcinoma. Cancer. 1997 80 1674-1679.
16. Galasko CS. Mechanisms of lytic and blastic metastatic disease of bone. Clin Orthop 1982 169 20-27. 7105580
17. Tamada T, Sone T, Tomomitsu T, Jo Y, Tanaka H, Fukunaga M. Biochemical markers for the detection of bone metastasis in patients with prostate cancer: Diagnostic efficacy and the effect of hormonal therapy. J Bone Miner Metab 2001 19 45-51. 10.1007/s007740170059
18. Koizumi M, Maeda H, Yoshimura K, Yamauchi T, Kawai T, Ogata E. Dissociation of bone formation markers in bone metastasis of prostate cancer. Br J Cancer 1997 75 1601-1604. 1:STN:280:ByiA38jltVM%3D
19. Takeuchi S, Arai K, Saitoh H, Yoshida K, Miura M. Urinary pyridinoline and deoxypyridinoline as potential markers of bone metastasis in patients with prostate cancer. J Urol 1996 156 1691-1695. 10.1097/ 00005392-199611000-00040
20. Koizumi M, Yamada Y, Takiguchi T, et al. Bone metabolic markers in bone metastases. J Cancer Res Clin Oncol 1995 121 542-548. 1:STN:280:BymD3svgtVI%3D
21. Scher HI, Chung LWK. Bone metastases: Improving the therapeutic index. Semin Oncol 1994 21 630-656. 1:STN:280:ByqD38ngtFE%3D
22. Percival RC, Urwin GH, Harris S, et al. Biochemical and histological evidence that carcinoma of the prostate is associated with increased bone resorption. Eur J Surg Oncol 1987 13 41-49. 1:STN:280:BiiC3svivFI%3D
23. Urwin GH, Percival RC, Harris S, Beneton MNC, Williams JL, Kanis JA. Generalised increase in bone resorption in carcinoma of the prostate. Br J Urol 1985 57 721-723. 1:STN:280:BimC3cvovVQ%3D
24. Roudier MP, Vesselle H, True LD, Higano CS, Ott SM, King SH, Vessella RL. Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: The effect of bisphosphonate therapy on bone scintigraphy results. Clin Exp Metastas 2003 20 171-180. 10.1023/A:1022627421000
25. Roland SI. Calcium studies in ten cases of osteoblastic prostatic metastasis. J Urol 1958 79 339-342. 1:STN:280:CyeD2MjnsVA%3D
26. Heidenreich A, Hofmann R, Engelmann UH. The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer. J Urol 2001 165 136-140. 10.1097/ 00005392-200101000-00033
27. Adami S. Salvagno G, Guarrera G, et al. Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton. J Urol 1985 134 1152-1154. 1:STN:280:BimD3sjlsFQ%3D
28. Percival RC, Watson ME, Williams JL, Kanis JA. Carcinoma of the prostate: Remission of paraparesis with inhibitors of bone resorption. Postgrad Med J 1985 61 551-553. 1:STN:280:BiqB2c3ltlU%3D
29. Kylmälä T, Tammela T, Risteli L, Risteli J, Taube T, Elomaa I. Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites: A controlled trial of the Finnish prostate cancer group. Eur J Cancer 1993 29 821-825.
30. Vinholes J, Guo C-Y, Purohit OP, Eastell R, Coleman RE. Metabolic effects of pamidronate in patients with metastatic bone disease. Br J Cancer 1996 73 1089-1095.
31. Garnero P, Buchs N, Zekri J, Rizzoli R, Coleman RE, Delmas PD. Markers of bone turnover for the management of patients with bone metastases from prostate cancer. Br J Cancer 2000 82 858-864. 10.1054/bjoc.1999.1012